Novo Nordisk
Novo’s diabetes treatment semaglutide gets unanimous FDA backing
October 19, 2017Sales and Marketing Novo Nordisk, diabetes, semaglutide
Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one …
Novo Nordisk Egypt promotes new General Manager
September 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, biotech, drugs, pharma, pharmaceutical
Novo Nordisk Egypt has promoted Hassan Fahmi to become its new General Manager for operations within the company. Fahmi arrived …
Novo’s Xultophy beats basal insulin in cutting cardiovascular risk
September 14, 2017Research and Development Novo Nordisk, Xultophy, diabetes, pharma, pharmaceutical, type 2 diabetes
Novo Nordisk has unveiled new data on its diabetes treatment Xultophy (insulin degludec/liraglutide) which supports its efficacy in reducing risk …
Novo Nordisk settles lawsuit over illegal marketing practices for $58.7 million
September 6, 2017Research and Development, Sales and Marketing FDA, Novo Nordisk, US, US Justice Department, Victoza, diabetes, pharma, pharmaceutical
Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities …
Novo diabetes drug outperforms Lilly rival at Phase 3
August 17, 2017Research and Development Eli Lilly, Novo Nordisk, diabetes, life sciences, medicine, pharma, pharmaceutical, type 2 diabetes
Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …
Novo Nordisk reshuffles Executive Management team with two major additions
August 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment, life sciences, medicine, pharma, pharmaceutical
This month has seen two new additions to Novo Nordisk’s Executive Management team. First of the pair is Camila Sylvest, …
Radius bolsters leadership with appointment of Novo Vet
July 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Radius, biotech, drugs, pharma, pharmaceutical
Jesper Høiland has been revealed as the new President and Chief Executive Officer of Radius. The news comes shortly after …
Novo Nordisk’s diabetes drug recommended for expanded indication in Europe
June 27, 2017Research and Development, Sales and Marketing CHMP, EMA, EU, Novo Nordisk, Victoza
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to expand the indication of Novo …
Promising Phase 2 obesity data for Novo’s diabetes drug
June 26, 2017Research and Development, Sales and Marketing Novo Nordisk
Novo Nordisk is hopeful about the prospects of its diabetes drug semaglutide as a treatment for obesity after it produced …
FDA backs Novo’s diabetes drug for cardiovascular efficacy
June 21, 2017Research and Development Novo Nordisk, Victoza
Good news for Novo Nordisk as the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA recommends that data …
Novo Nordisk eyes acquisition of Global Blood Therapeutics
March 9, 2017Sales and Marketing Global Blood Therapeutics, Novo Nordisk
Novo Nordisk has been notoriously shy when it comes to making acquisitions but Reuters has reported that this may be …
Novo Nordisk’s Head of North America resigns
March 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment
Novo Nordisk has announced the surprising news that its Executive Vice President, Head of North American Operations Jakob Riis has …
Death in trial of Roche’s potential blockbuster haemophilia drug
February 24, 2017Medical Communications, Research and Development Novo Nordisk, Roche, Shire, haemophilia
Roche has reported a death in the trial of its haemophilia treatment, emicizumab, that will only add to safety concerns …
Price-fixing class action lawsuit levelled at three major insulin producers
January 31, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing
A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …
Novo Nordisk launches £115 million investment in UK despite Brexit
January 30, 2017Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit
Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …
